Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

279 ARTÍCULOS , VIENDO DEL 226 AL 240

Deutetrabenazine Therapy and CYP2D6 Genotype

Dean L.

2019 May 1. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–.

Parkinson Disease Agents

2021 Oct 25. LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.

Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia

Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Müller DJ, Kennedy JL.

Pharmacogenomics J. 2012 Jun;12(3):260-6. doi: 10.1038/tpj.2010.93. Epub 2011 Jan 25.

The effects of a novel histamine-3 receptor inverse agonist on essential tremor in comparison to stable levels of alcohol

Zoethout RW, Iannone R, Bloem BR, Palcza J, Murphy G, Chodakewitz J, Buntinx A, Gottesdiener K, Marsilio S, Rosen L, van Dyck K, Louis ED, Cohen AF, Schoemaker RC, Tokita S, Sato N, Koblan KS, Hargreaves RH, Renger J, van Gerven JM.

J Psychopharmacol. 2012 Feb;26(2):292-302. doi: 10.1177/0269881111398685. Epub 2011 Feb 18.

LINGO1 variants in essential tremor and Parkinson's disease

Deng H, Gu S, Jankovic J.

Acta Neurol Scand. 2012 Jan;125(1):1-7. doi: 10.1111/j.1600-0404.2011.01516.x. Epub 2011 Apr 7.

Septo-optic dysplasia-plus and dyskinetic cerebral palsy in a child

Trabacca A, De Rinaldis M, Gennaro L, Losito L.

Neurol Sci. 2012 Feb;33(1):159-63. doi: 10.1007/s10072-011-0590-8. Epub 2011 Apr 30.

Deep brain stimulation and the role of astrocytes

Vedam-Mai V, van Battum EY, Kamphuis W, Feenstra MG, Denys D, Reynolds BA, Okun MS, Hol EM.

Mol Psychiatry. 2012 Feb;17(2):124-31, 115. doi: 10.1038/mp.2011.61. Epub 2011 May 31.

Clinical characteristics of essential tremor in Taiwan: an exploratory-comparative study

Chuang WL, Lu CS, Huang YZ, Chen RS.

Eur J Neurol. 2012 Jan;19(1):135-41. doi: 10.1111/j.1468-1331.2011.03459.x. Epub 2011 Jun 27.

Asymmetric chorea as presenting symptom in Graves' disease

Park J, Kim JG, Park SP, Lee HW.

Neurol Sci. 2012 Apr;33(2):343-5. doi: 10.1007/s10072-011-0679-0. Epub 2011 Jul 28.

Successful treatment of two paediatric cases of anti-NMDA receptor encephalitis with cyclophosphamide: the need for early aggressive immunotherapy in tumour negative paediatric patients

Kashyape P, Taylor E, Ng J, Krishnakumar D, Kirkham F, Whitney A.

Eur J Paediatr Neurol. 2012 Jan;16(1):74-8. doi: 10.1016/j.ejpn.2011.07.005. Epub 2011 Aug 9.

Genetically engineered mouse models of Parkinson's disease

Crabtree DM, Zhang J.

Brain Res Bull. 2012 May 1;88(1):13-32. doi: 10.1016/j.brainresbull.2011.07.019. Epub 2011 Aug 3.

Mitochondrial dysfunction in genetic animal models of Parkinson's disease

Trancikova A, Tsika E, Moore DJ.

Antioxid Redox Signal. 2012 May 1;16(9):896-919. doi: 10.1089/ars.2011.4200. Epub 2011 Oct 4.

Treatment of sydenham chorea with intravenous immunoglobulin

Walker K, Brink A, Lawrenson J, Mathiassen W, Wilmshurst JM.

J Child Neurol. 2012 Feb;27(2):147-55. doi: 10.1177/0883073811414058. Epub 2011 Aug 24.

Clinical failure of botulinum toxin A in movement disorders

Savica R, Grossardt BR, Bower JH, Klassen BT, Matsumoto JY.

Parkinsonism Relat Disord. 2012 Jan;18(1):73-5. doi: 10.1016/j.parkreldis.2011.07.016. Epub 2011 Aug 30.

Anxiety in Parkinson's disease: a critical review of experimental and clinical studies

Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA.

Neuropharmacology. 2012 Jan;62(1):115-24. doi: 10.1016/j.neuropharm.2011.08.039. Epub 2011 Aug 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias